Chicago Equity Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Chicago Equity Partners’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$716K	Buy	15,140 +3,990	+36%	+$222K	0.07%	338
2019 Q4	$674K	Sell	11,150 -120	-1%	-$7.15K	0.04%	569
2019 Q3	$675K	Sell	11,270 -3,510	-24%	-$229K	0.03%	606
2019 Q2	$950K	Buy	14,780 +5,350	+57%	+$378K	0.04%	529
2019 Q1	$765K	Buy	+9,430	New	+$608K	0.03%	583
2018 Q3	–	Sell	-33,010	Closed	-$1.38M	–	839
2018 Q2	$1.38M	Sell	33,010 -5,845	-15%	-$259K	0.04%	457
2018 Q1	$1.71M	Hold	38,855	–	–	0.05%	403
2017 Q4	$1.95M	Hold	38,855	–	–	0.06%	372
2017 Q3	$1.97M	Buy	38,855 +11,085	+40%	+$581K	0.06%	374
2017 Q2	$1.41M	Buy	+27,770	New	+$1.29M	0.04%	435
2013 Q4	–	Sell	-7,550	Closed	-$283K	–	446
2013 Q3	$283K	Hold	7,550	–	–	0.01%	380
2013 Q2	$202K	Buy	+7,550	New	+$161K	0.01%	410

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Chicago Equity Partners's IONS Position: Q1 2020 in Review

Chicago Equity Partners increased its Ionis Pharmaceuticals (IONS) stake by 36% in Q1 2020, buying an estimated $222K and bringing the position to 15,140 shares worth $716K. The position accounts for 0.07% of the portfolio, ranked #338.

Chicago Equity Partners first reported a position in IONS in Q2 2013 and has held it in 12 quarters since. The position peaked at $1.97M in Q3 2017. 362 funds tracked by Wall St. Rank hold IONS as of Q1 2020.

Chicago Equity Partners held 15,140 shares of Ionis Pharmaceuticals worth $716K as of Q1 2020.
Chicago Equity Partners bought 3,990 Ionis Pharmaceuticals shares in Q1 2020, an estimated $222K.
Ionis Pharmaceuticals made up 0.07% of Chicago Equity Partners's portfolio in Q1 2020, its #338 holding.
Chicago Equity Partners first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 12 quarters since.
Chicago Equity Partners's Ionis Pharmaceuticals position peaked at $1.97M in Q3 2017.
362 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.